The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.

All material subject to strictly enforced copyright laws. © 2022 Euromoney, a part of the Euromoney Institutional Investor PLC.

Don’t follow the bear

The IPO market in China has been variously described as dormant, slow or just plain dull. With respect to one IPO that got shelved last month, you might say hibernation was a more appropriate term. Fujian Guizhentang Pharmaceutical pulled its planned IPO after a public outcry over its seemingly utterly disgusting business of bear-bile extraction.

If there is a prize for clearest demonstration of bear-market sentiment, this one wins by a country bile.

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree